Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Yale School of Medicine, New Haven, Connecticut Nemours Children's Health, Wilmington, Delaware Helen DeVos Children's Hospital, Grand Rapids, Michigan Washington University School of Medicine, St Louis, Missouri